| Autor: |
Giuseppe Miragliotta, Anna Di Taranto, Rossella De Nittis, Raffaele Antonetti, Raffaele Del Prete, Adriana Mosca |
| Jazyk: |
English<br />Italian |
| Rok vydání: |
2009 |
| Předmět: |
|
| Zdroj: |
Microbiologia Medica, Vol 24, Iss 3 (2009) |
| Druh dokumentu: |
article |
| ISSN: |
2280-6423 |
| DOI: |
10.4081/mm.2009.2530 |
| Popis: |
Infections caused by extended-spectrum beta-lactamase (ESBL) producing E. coli and K. pneumoniae limit therapeutical options.The objective of this study was to evaluate the activity of ciprofloxacin, imipenem, amikacin and piperacillin/tazobactam against ESBL-producing E. coli and K. pneumoniae strains isolated from patients admitted to Ospedali Riuniti, Foggia, over the period January-December 2007. A total of 1013 E. coli and 146 K. pneumoniae were isolated from various clinical specimens. 111/1013 (10.9%) and 24/146 (16.4%) were confirmed as ESBL-producing strains by both the Phoenix system (Becton & Dickinson) and the E-test (bioMérieux, Italia). Both the ESBL producing enterobacteria showed a high degree resistance to ciprofloxacin; in addition, K. pneumoniae exhibited resistance also to piperacillin/tazobactam. Imipenem was the most effective antibiotic with the exception of one strain ESBL-positive K. pneumoniae. A similar pattern was showed by amikacin. In view of the increasing prevalence of ESBL strains it appears important a continuous antimicrobial monitoring. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
